• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail

Division of Oncology Products 1 (DOP1)

Director: Anthony Murgo (Acting)
Deputy Director: Amna Ibrahim, M.D.
Deputy Director of Safety: Yang-Min (Max) Ning (Acting)

 

Safety Regulatory Project Manager (SRPM): Susan Jenney
Chief Project Management Staff: Christy Cottrell
Chief Project Management Staff: Alice Kacuba
 
Secretary: Dolores Bowen

The Division of Oncology Products 1 (DOP1) regulates Investigational New Drug Applications (INDs), New Drug Applications (NDAs) and Biologic Licensing Applications (BLAs) for the following therapeutics areas:

  1. Breast Cancer
  2. Gynecologic Cancers
  3. Genitourinary Cancers
  4. Supportive care (non-hematologic) Products

Mailing Address:
Food and Drug Administration
Center for Drug Evaluation and Research
Division of Oncology Products 1 (DOP1)
5901-B Ammendale Road
Beltsville, MD 20705-1266

Phone:  (301) 796-2330
Fax: (301) 796-9845